| Name | Title | Contact Details |
|---|
JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.
Neo Dental International is a Federal Way, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.
Tactile Systems Technology Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Physio-Control, now part of Stryker, is the world leader in the development, manufacture, sale and service of external defibrillator/monitors and emergency medical response products and services. We envision a world in which no person dies suddenly as a result of an acute, treatable medical event. Physio-Control Team Members are part of a unique group who love what they do - and why they do it. Our Team is comprised of talented individuals who have purpose, creativity and passion, and we are proud to be leading the industry dedicated to saving and extending lives around the globe. Our Team Members are our most valuable asset and what sets us apart from our competitors. We are committed to our mission to save lives through hard work and dedication.